Principia Biopharma Inc, 220 E Grand Ave, South San Francisco, CA 94080, US

Senti Biosciences, Inc is a biotechnology company based in South San Francisco, CA that is dedicated to developing a new generation of intelligent medicines to combat complex diseases. They utilize their proprietary gene circuit technology platform to design and optimize DNA sequences, reprogramming cells with biological logic to sense, compute, and respond to their environment. With a focus on off-the-shelf CAR-NK cells, gene therapies, and cell therapies, Senti Bio aims to address major challenges in oncology and other therapeutic areas. By harnessing the potential of synthetic biology, Senti Bio is at the forefront of engineering smarter medicines that have the ability to outmaneuver diseases. Their innovative approach of programming cells with gene circuits allows for the development of product candidates that can be used against a wide range of diseases, including oncology, immunology, neuroscience, cardiovascular disease, regenerative medicine, and genetic disease. With a commitment to continuous learning and a world-class team, Senti Bio is dedicated to creating a future where intelligent medicines revolutionize healthcare.Generated from the website